For research use only. Not for therapeutic Use.
Ruboxistaurin mesylate (Cat.No:I002303) is a kinase inhibitor used in medical research and clinical trials. It targets protein kinase C beta (PKCβ), an enzyme involved in cell signaling pathways. Ruboxistaurin mesylate has shown promise in preclinical studies for its potential applications in the treatment of diabetic retinopathy and diabetic nephropathy.
| Catalog Number | I002303 |
| CAS Number | 192050-59-2 |
| Synonyms | LY 333531 mesylate; Ruboxistaurin mesylate |
| Purity | ≥95% |
| Target | TGF-beta/Smad |
| InChI | 1S/C28H28N4O3.CH4O3S/c1-30(2)15-18-11-12-31-16-21(19-7-3-5-9-23(19)31)25-26(28(34)29-27(25)33)22-17-32(13-14-35-18)24-10-6-4-8-20(22)24;1-5(2,3)4/h3-10,16-18H,11-15H2,1-2H3,(H,29,33,34);1H3,(H,2,3,4)/t18-;/m0./s1 |
| InChIKey | DUHQBKLTAVUXFF-FERBBOLQSA-N |
| SMILES | CN(C)<wbr>C[C@@H]1CCn2cc(c3c2cccc3)<wbr>C4=C(c5cn(c6c5cccc6)<wbr>CCO1)<wbr>C(=O)<wbr>NC4=O.CS(=O)<wbr>(=O)<wbr>O |
